Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasonex for Nasal Congestion in Seasonal Allergic Rhinitis
NCT00732381Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Aug 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in seasonal allergic rhinitis (SAR) comparing Nasonex Arm with Placebo Arm (2 arms). Primary endpoint: Change From Baseline in Average AM/PM PRIOR Nasal Congestion Score at 15 days. Started Aug 2008; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00732381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00732381.